We are Investigational Medicinal Product specialists with experience in clinical trials across phase 1 to 3 including First-in-Human Advanced Therapy Investigational Medicinal Products as well as experience in double blinded studies.

Having supported academia sponsors we have gained experience in some of the challenges involved with complex studies and risk mitigation strategies for IMPs.

We have links to CMC specialists who can provide technical support for IMPD writing/reviews

Our close working relationship with NHS means we understand the challenges of setting up studies and the key considerations during product development and formulation to enable smooth IMP management at site pharmacy